| NAME |
AMYLASE 149,900UNIT/LIPASE 37,000UNIT/PROTEASE 97,300UNIT CAP,EC |
| VA GENERIC NAME |
AMYLASE/LIPASE/PROTEASE |
| DOSAGE FORM |
CAP,EC |
| FDA MED GUIDE |
Pancrelipase_(Pancreaze)_(2021).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| NATIONAL FORMULARY NAME |
AMYLASE/LIPASE/PROTEASE CAP,EC |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2021-06-24 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
PANCREAZE 37,000UNIT EC CAP |
| VA PRODUCT IDENTIFIER |
P1292 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
CAP |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4040591 |
| EFFECTIVE DATE/TIME |
-
- 2021-06-24 00:00:00
- STATUS: ACTIVE
-
- 2021-06-24 00:00:00
- STATUS: ACTIVE
-
- 2021-06-24 00:00:00
- STATUS: ACTIVE
-
- 2021-06-24 00:00:00
- STATUS: ACTIVE
|